Ownership
Private
Therapeutic Areas
Men's HealthRare DiseasesHematologyDermatologyNeurologyCardiovascularNephrologyInfectious Diseases
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small moleculeBiologicRecombinant protein

Farmatek General Information

Farmatek is an established Turkish pharmaceutical manufacturer with EU GMP certification, offering a broad portfolio across multiple therapeutic areas including dermatology, nephrology, hematology, anti-infectives, urology, CNS disorders, cardiovascular disease, and rare diseases. It provides both branded products for the Turkish market and contract manufacturing services for international partners.

Contact Information

Primary Industry
Biotech
Corporate Office
Ümraniye, Istanbul
Turkey

Drug Pipeline

No pipeline data available

For full access to Farmatek's pipeline data

Book a demo

Key Partnerships

Offers CMO/CDMO services to other pharma companies

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Farmatek Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Farmatek's complete valuation and funding history, request access »

Farmatek Financial Metrics